Transverse myelitis treatments are designed to manage and alleviate symptoms and largely depend upon the severity of neurological involvement. Written by : Editorial Team Updated at: Jan 11, 2013 ...

Q Therapeutics announced that Q-Cells (human glial restricted progenitor cells and their progeny), an adult cell product, has been granted Orphan Drug Designation for the treatment of transverse ...

DUBLIN--(BUSINESS WIRE)--The "Transverse Myelitis - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Transverse Myelitis Pipeline Insight, 2020 outlays ...

Acute Flaccid Myelitis (AFM) is a rare disease that affects children aged 3 to 15 years. The disease involves inflammation of the spinal cord and leads to serious implications for those affected.

Today, the Columbus-based Transverse Myelitis Association has grown from a grassroots operation into a full-fledged organization with 12,000 or so members in more than 100 countries.

Treatment considerations ultimately will depend on the results of her MRI. ... Her current diagnosis is transverse myelitis, in addition to a possible remote multiple sclerosis (MS) ...

Acute flaccid myelitis is a polio-like syndrome that causes weakened muscles and, sometimes, paralysis. There's no cure, but it remains extremely rare.